Business
Medicus Pharma Ltd. To Present at Brookline Capital Markets
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, a next generation GnRH Antagonist as a first in ...
About this update from Medicus Pharma Ltd.
[{"type":"text","content":"The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer","length":336,"tagName":"p"},{"type":"text","content":"D-MNA and Teverelix collectively represent ~$8 billion in potential market opportunity","length":86,"tagName":"p"},{"type":"text","content":"PHILADELPHIA, PA / ACCESS Newswire / September 24, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that members of its executive management team will participate in a live fireside chat on Monday, September 29, 2025, hosted by Kumaraguru (Kumar) Raja, Ph.D., Senior Biotechnology Analyst at Brookline Capital Markets.","length":527,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"padding:0in 5.4pt;vertical-align:top;width:76.25pt;","val":[{"type":"text","content":"Event:","length":6,"tagName":"p","attribs":{}}]},{"style":"padding:0in 5.4pt;vertical-align:top;width:391.25pt;","val":[{"type":"text","content":"Fireside Chat with Kumar Raja, Ph.D, Brookline Capital Markets Senior Biotech Analyst","length":85,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"padding:0in 5.4pt;vertical-align:top;width:76.25pt;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"padding:0in 5.4pt;vertical-align:top;width:391.25pt;","val":[{"type":"text","content":"Monday, September 29, 2025","length":26,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"padding:0in 5.4pt;vertical-align:top;width:76.25pt;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"style":"padding:0in 5.4pt;vertical-align:top;width:391.25pt;","val":[{"type":"text","content":"11:00 a.m. to 12:00 p.m. Eastern Time","length":37,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"padding:0in 5.4pt;vertical-align:top;width:76.25pt;","val":[{"type":"text","content":"Registration:","length":13,"tagName":"p","attribs":{}}]},{"style":"padding:0in 5.4pt;vertical-align:...